Hang Seng Composite Index Series

Zhenro Properties Announces Annual Results 2021

Retrieved on: 
Thursday, March 31, 2022
Company, Post, Real estate investment trust, Relaxation, Growth, Motherboard, Board, City, Compliance, ESG, Pressure, Main Board for Serb Liberation, GFA, Industry, Hang Seng Composite Index Series, BBB, Year, Policy, MSCI, Efficiency, Hong Kong Stock Exchange, Airline, Cryptocurrency, Real estate, Bank, Lithium, Group, PRC

HONG KONG, Mar 31, 2022 - (ACN Newswire) - Zhenro Properties Group Limited ("Zhenro Properties" or "the Group"; stock code: 6158), a leading PRC property developer, announced its audited annual results for the year ended 31 December 2021 (the "Year").

Key Points: 
  • HONG KONG, Mar 31, 2022 - (ACN Newswire) - Zhenro Properties Group Limited ("Zhenro Properties" or "the Group"; stock code: 6158), a leading PRC property developer, announced its audited annual results for the year ended 31 December 2021 (the "Year").
  • As at 31 December 2021, a total of 22 projects of Zhenro Properties were granted China 2- or 3-star green building certificates, with a total GFA of 2.4 million sq.m.
  • Zhenro Properties Group Limited is a leading property developer in the PRC with nationwide business presence in six key economic regions.
  • Zhenro Properties was listed on the Main Board of the Hong Kong Stock Exchange in 2018.

Redsun Properties 2021 Annual Revenue Increases 32.3% to RMB26.67 Billion, Gross Profit Ups 12.7% to RMB5.08 Billion

Retrieved on: 
Thursday, March 31, 2022
The Group, Hang Seng Composite Index Series, Group, Growth, City, Development, Light, Industry, Efficiency, Acquisition, Synergy, IP, Commercial property, Bank, Yangtze Delta

in 2021, representing a year-on-year increase of 15.5%

Key Points: 
  • in 2021, representing a year-on-year increase of 15.5%
    -- Revenue amounted to RMB26.67 billion, representing an increase of 32.3% as compared with 2020.
  • The gross profit was RMB5.08 billion, with a year-on-year increase of 12.7%, where the gross profit margin amounted to 19.1%.
  • The net profit was RMB1.87 billion, and the core net profit was up 3.5% to RMB1.47 billion; the net profit margin was 7.0%, which remained at the industry average level.
  • While developing residential properties, Redsun Properties also operates commercial complexes covering shopping malls, amusement parks and community centers, hotels and office buildings.

Huijing Holdings Contracted Sales Continued to Grow to RMB8 Billion, Revenue Steadily Increased to RMB5.31 Billion

Retrieved on: 
Wednesday, March 30, 2022
The Group, Letter, Hang Seng Composite Index Series, Urban renewal, Seemabaddha, Growth, Board, City, Research, Guangdong-Hong Kong-Macau Greater Bay Area, Yangtze, Board of directors, CEO, Intelligence, GFA, Children's right to adequate nutrition in New Zealand, Industry, Technology, Town Planning Board, Bihar State Power Holding Company Limited, Hang Seng Index, Ecosystem, Science, Information technology, Policy, News, Airline, Renewable energy, Group, PRC

Contracted sales have amounted to approximately RMB8.0 billion, representing a year-on-year increase of 3.9%.

Key Points: 
  • Contracted sales have amounted to approximately RMB8.0 billion, representing a year-on-year increase of 3.9%.
  • The Board of Directors (the "Board") has proposed to distribute a final dividend of HK2.48 cents per share.
  • During the Year, the Group has recorded a revenue of approximately RMB5.31 billion, an increase of 3.0% from the corresponding period last year.
  • Thanks to its overall market analysis, the Group recorded a continuous improvement in revenue, with total assets increasing 19.2% year-on-year to RMB15.2 billion.

China Risun's 2021 Annual Profit Attributable to Owners Ups 58.1% to RMB2.61 billion

Retrieved on: 
Monday, March 28, 2022
Momentum, Method, Miramar Hotel and Investment, Hang Seng Composite Index Series, Group, Hydrogen, Hang Seng Index, Coke, Transport, Growth, Hydrogenation, Russell Midcap Index, Board, FTSE, Dongming County, Carbon, FTSE SmallCap Index, Frost & Sullivan, FTSE Global Equity Index Series, Industry, Technology, Fruit, Styrene, Caprolactam, Income, Acquisition, Dual carbon battery, LMS, Hong Kong Stock Exchange, Radiation, Coal, Rail transport, Oil

Profit attributable to owners up 58.1% to RMB2.61 billion, achieving a 3-year consecutive growth since its listing in 2019.

Key Points: 
  • Profit attributable to owners up 58.1% to RMB2.61 billion, achieving a 3-year consecutive growth since its listing in 2019.
  • Revenue for the year ended 31 December 2021 was RMB38.4 billion, representing an increase of 94.2% year-on-year.
  • In 2021, the price of coke reached a record high in China, and the profitability of the industry continued to improve.
  • As the core profit source of China Risun, the coke business performed very well.

Nissin Foods Announces 2021 Annual Results, Financial Performance Exceeds High 2020 Baseline

Retrieved on: 
Tuesday, March 22, 2022
Nissin Foods, Cup Noodles, Company, EBITDA, Miramar Hotel and Investment, Hang Seng Composite Index Series, ECO Cup, Group, Growth, Board, Doll, Supermarket, Drink, Hong Kong Stock Exchange, Flour, FTSE SmallCap Index, Safety, Technology, Powder, Goal, Food science, Time, Stock exchange, COVID-19, Vegetable, Taste, Yoy, Cup noodle, Efficiency, Hang Seng Index, Property management, Convenience food, Fast food, Mainland China, Mainland

The Group's EBITDA grew by 6.0% YoY to HK$604.1 million (2020: HK$570.0 million), representing an EBITDA margin of 15.6% (2020: 16.2%).

Key Points: 
  • The Group's EBITDA grew by 6.0% YoY to HK$604.1 million (2020: HK$570.0 million), representing an EBITDA margin of 15.6% (2020: 16.2%).
  • Profit attributable to owners of the Company increased by 0.6% YoY to HK$303.8 million (2020: HK$301.9 million), representing a net profit margin of 7.9% (2020: 8.6%).
  • Revenue in the Mainland China operations recorded strong growth in the review year, surpassing the high baseline set in 2020.
  • Consequently, the Group's 2021 financial performance has been able to exceed the high baseline set in 2020.

Li Auto Announces Inclusion of Its Shares in the Shenzhen-Hong Kong Stock Connect Program

Retrieved on: 
Monday, March 14, 2022
Family, Annual report, Private Securities Litigation Reform Act, Shenzhen Stock Exchange, Company, Hang Seng Composite Index Series, Bev Perdue, SUV, LI, U.S. Securities and Exchange Commission, Stock exchange, Shenzhen-Hong Kong Stock Connect, GLOBE, Erev Shel Shoshanim, Technology, Hong Kong Stock Exchange, Hang Seng Index, SEC, Shanghai-Hong Kong Stock Connect, Happiness, Terminology, Forward-looking statement, Risk management

The inclusion in the Shenzhen-Hong Kong Stock Connect program allows the Company to access a broader investor base and share its growth trajectory and further success with users, partners and investors in mainland China via the financial market.

Key Points: 
  • The inclusion in the Shenzhen-Hong Kong Stock Connect program allows the Company to access a broader investor base and share its growth trajectory and further success with users, partners and investors in mainland China via the financial market.
  • The Shenzhen-Hong Kong Stock Connect program is a mutual stock market access mechanism under which the Shenzhen Stock Exchange and the Stock Exchange of Hong Kong Limited have established technical connectivity to enable investors in Mainland China and the Hong Kong Special Administrative Region to trade eligible shares listed on each others market through their local securities companies or brokers.
  • Li Auto Inc. is an innovator in Chinas new energy vehicle market.
  • The Company started volume production of Li ONE in November 2019 and released the 2021 Li ONE in May 2021.

TCL Electronics (01070.HK) Revenue in 2021 Increased by 46.9% YoY to HK$74.85 Billion

Retrieved on: 
Friday, March 11, 2022
Benchmark, Hang Seng Index, Internet, ESG, No, CES, TOKYO, Netflix, IOT, ASP, Ecosystem, Growth, TCL Electronics, Industry, ARPU, FTSE SmallCap Index, Company, Marketing, Electronics, Tencent, RESEARCH, TCL, Hang Seng Composite Index Series, QLED, Statistics, TSR, AR, Yoy, Mini, Cayman, R, Possibility, Hong Kong Stock Exchange, Research, Pressure, Android, Shenzhen-Hong Kong Stock Connect, Channel, IOE, Investment, Carbon, Board, Efficiency, Smartglasses, Roku, DingTalk, Group, Technology/Transformation: Wonder Woman, COVID-19, LTD, Airline, Renewable energy, Television, Video game, Mobile phone, PRC, Google

Global Revenue from TCL Smart Screen Display Business Increased by 24.3% YoY to HK$49.27 Billion, Ranking No.

Key Points: 
  • Global Revenue from TCL Smart Screen Display Business Increased by 24.3% YoY to HK$49.27 Billion, Ranking No.
  • However, the global market share of TCL smart screen continued to increase to 11.5%[2] in 2021, firmly ranking No.
  • Seen from regional markets, the sales revenue of TCL smart screen in North American markets increased by 24.8% year-on-year.
  • In 2021, the Company's revenue from all-category sales and marketing increased by 70.7% year-on-year to HK$6.37 billion.

EC Healthcare Launch Tele-Medicine and Drug Delivery Service, Reduce Infection Risk and Protect Citizen's Health

Retrieved on: 
Wednesday, March 9, 2022
Hypertension, Cardiology, PCR, Risk, Hang Seng Composite Index Series, Infection, Diarrhea, UMH, AI, Diabetes, Customer service, Rash, Conditional sentence, Precision medicine, NEW, SEHK, Hyperlipidemia, HAIR, KONG, HEALTH, Group, Professional, Intelligence, Medicine, Obstetrics, Sinusitis, Health insurance, Pharmaceutical industry, Hospital

Please book via EC Healthcare online platform: https://ectelemedicine.echealthcare.com/

Key Points: 
  • Please book via EC Healthcare online platform: https://ectelemedicine.echealthcare.com/
    If you have any enquiry, please contact Customer Service Hotline: 2152 8503
    The Tele-Medicine mainly provides common diseases consultation and chronic disease follow-up consultation.
  • After the teleconsultation, the Group will also arrange a drug delivery service within four hours*.
  • The Group is devoted to being the public's health guardian, serving the community, and contributing to the anti-epidemic work.
  • The Group principally engages in the provision of one-stop medical and health care services in Greater China.

EC Healthcare's Chairman Eddy Tang Further Increases Shareholdings With Strong Confidence in the Group's Future Development

Retrieved on: 
Wednesday, March 9, 2022
Cardiology, Company, Hang Seng Composite Index Series, UMH, Precision medicine, NEW, SEHK, HAIR, KONG, HEALTH, Group, Professional, Intelligence, Obstetrics, Hospital

Prior to this transaction, Mr. Tang had already increased shareholdings 3 times this year with a total of 1.15 million increased shares and the average price was $9.194, $8.49 & $8.18 per share.

Key Points: 
  • Prior to this transaction, Mr. Tang had already increased shareholdings 3 times this year with a total of 1.15 million increased shares and the average price was $9.194, $8.49 & $8.18 per share.
  • Looking forward, the Group remain confident for the long-term strong business growth momentum and will keep investing in IT, brand and service to provide better services to the public.
  • The Group is a constituent stock of Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.
  • The Group principally engages in the provision of one-stop medical and health care services in Greater China.

EC Healthcare Included as an Eligible Stock of the Shenzhen - Hong Kong Stock Connect

Retrieved on: 
Monday, March 7, 2022
NEW, Intelligence, KONG, Shenzhen Stock Exchange, Hang Seng Composite Index Series, HAIR, SEHK, Growth, HEALTH, Precision medicine, SPINE, Company, Obstetrics, Professional, Shenzhen-Hong Kong Stock Connect, Cardiology, Group, UMH, Healthcare

HONG KONG, Mar 7, 2022 - (ACN Newswire) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Company has been included as an eligible stock of Shenzhen-Hong Kong Stock Connect, with effect from March 7, 2022, pursuant to the Announcement on Adjustment of the Stock List of Hong Kong Stock Connect issued by the Shenzhen Stock Exchange on March 7, 2022.

Key Points: 
  • HONG KONG, Mar 7, 2022 - (ACN Newswire) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Company has been included as an eligible stock of Shenzhen-Hong Kong Stock Connect, with effect from March 7, 2022, pursuant to the Announcement on Adjustment of the Stock List of Hong Kong Stock Connect issued by the Shenzhen Stock Exchange on March 7, 2022.
  • Mainland investors can directly trade the Company's stock after the Company is included as an eligible stock of the Shenzhen - Hong Kong stock connect.
  • The Company believes the inclusion of the shares of the Company in the trading mechanism of Shenzhen-Hong Kong Stock Connect demonstrates market recognition of the Company's investment value and growth prospects.
  • The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.